Stocks · Health care · Biological Products, (No Diagnostic Substances)

EXELIXIS, INC.

EXEL Clue Score84

United States Fiscal year ends January CIK 0000939767 Results filed 29 Oct 2026

Add to watchlist

What the insiders did Net selling

Bought (120 mo)

$16.46M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$349.82M

$12.08M on a plan · $240.94M straight out of an exercise

Sold at will

$96.81M

131 of 440 sales

Net

−$333.37M

−$80.35M against sales at will